Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
16,765,425
-
Share change
-
-1,608,556
-
Total reported value
-
$51,146,915
-
Put/Call ratio
-
78%
-
Price per share
-
$3.05
-
Number of holders
-
54
-
Value change
-
-$6,369,466
-
Number of buys
-
20
-
Number of sells
-
34
Institutional Holders of ACELRX PHARMACEUTICALS INC - COM (ACRX) as of Q3 2015
As of 30 Sep 2015 ACELRX PHARMACEUTICALS INC - COM (ACRX) had 54 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 16,765,425 shares of stock of the company.
Largest 10 holders included PERCEPTIVE ADVISORS LLC, GRANAHAN INVESTMENT MANAGEMENT INC/MA, Palo Alto Investors, LLC, VANGUARD GROUP INC, FMR LLC, Cormorant Asset Management, LLC, BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., DEUTSCHE BANK AG\, and Spark Investment Management LLC.
This table shows 54 institutional shareholders of the security as of 30 Sep 2015.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.